Nana H. Overgaard
Kongens Lyngby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
Journal: Oncoimmunology
Published: January 17, 2022
Genetically Induced Tumors in the Oncopig Model Invoke an Antitumor Immune Response Dominated by Cytotoxic CD8β+ T Cells and Differentiated γδ T Cells Alongside a Regulatory Response Mediated by FOXP3+ T Cells and Immunoregulatory Molecules.
Journal: Frontiers in immunology
Published: February 19, 2018
KRASG12D and TP53R167H Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa Pigs.
Journal: Scientific reports
Published: February 14, 2018
Of Mice, Dogs, Pigs, and Men: Choosing the Appropriate Model for Immuno-Oncology Research.
Journal: ILAR journal
Published: November 10, 2017
Clinically-Relevant Rapamycin Treatment Regimens Enhance CD8+ Effector Memory T Cell Function In The Skin and Allow their Infiltration into Cutaneous Squamous Cell Carcinoma.
Journal: Oncoimmunology
Published: October 20, 2017
Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs.
Journal: Vaccine
Published: June 30, 2017
The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform.
Journal: Frontiers in oncology
Published: June 17, 2017
CD4+CD8β+ double-positive T cells in skin-draining lymph nodes respond to inflammatory signals from the skin.
Journal: Journal of leukocyte biology
Published: February 16, 2017
Establishing the pig as a large animal model for vaccine development against human cancer.
Journal: Frontiers in genetics
Published: July 01, 2015
CD4+/CD8+ double-positive T cells: more than just a developmental stage?
Journal: Journal of leukocyte biology
Published: November 01, 2014
Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients?
Journal: International journal of cancer
Published: July 09, 2014
Last Updated: 09/26/2026